Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRC-4016 Drug-Drug Interaction Study
NCT02367937Phase 1Completed
- Sponsor
- Pronova BioPharma
- Start
- Aug 2014
- Primary completion
- Oct 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of icosabutate in dyslipidemia and hypertriglyceridemia, sponsored by Pronova BioPharma. Primary endpoints: Area Under the Curve and Peak Plasma Concentration. Started Aug 2014; status: completed.
02
Drugs
icosabutate
03
Conditions
dyslipidemiahypertriglyceridemia
Beyond the preview
Go deeper on NCT02367937.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02367937.